Novartis is up 7.5%, or $6.24 to $89.83.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVS:
- Novartis’ NATALEE readout a ‘best case scenario,’ says BofA
- Morgan Stanley expects Novartis to outperform after Kisqali ‘positive surprise’
- Novartis says Kisqali Phase 3 NATALEE trial met primary endpoint at interim
- Novartis Up after Positive Topline Data
- 23andMe pilots program to raise awareness about Lipoprotein(a)